...
【24h】

Transscleral diode laser photocoagulation in refractory glaucoma.

机译:经巩膜二极管激光光凝治疗难治性青光眼。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND OBJECTIVE: Patients with glaucoma refractory to medical or surgical treatment are difficult to treat. The aim of this study was to evaluate the effect of contact transscleral diode laser cyclophotocoagulation (DLPC) on these patients' intra-ocular pressure (IOP) and visual acuity. PATIENTS AND METHODS: 37 eyes of 36 patients who suffered from refractory glaucoma and who had undergone DLPC, were followed at the Eye Clinic of Verona University for an average of 14 +/- 4 months. The average age was 54 +/- 26 years. IOP, visual acuity and ocular complications were analysed. RESULTS: A total of 71 treatments were given. More than 1 treatment was given in 22 eyes (59%). The mean pretreatment IOP was 33.1 +/- 3.3 mm Hg. At the last follow-up, the mean IOP was 21 +/- 1.6 mm Hg. Mean total medications were reduced from 4.4 +/- 0.5 to 2.4 +/- 0.3. No serious complications occurred in 71 treatments. Visual acuity remained stable in 25 eyes (67.5%), improved in 6 eyes (16.2%) and decreased in 6 eyes (16.2%). CONCLUSIONS: DLPC is effective in lowering IOP in eyes with refractory glaucoma. It also serves to reduce the number of antiglaucoma medications. This procedure is relatively safe. Nevertheless, multiple DLPC applications may be needed. Copyright 2001 S. Karger AG, Basel
机译:背景与目的:难于接受医学或外科手术治疗的青光眼患者。这项研究的目的是评估接触式跨巩膜二极管激光循环光凝术(DLPC)对这些患者的眼内压(IOP)和视力的影响。患者与方法:在维罗纳大学眼科诊所对36例难治性青光眼患者进行了DLPC,其中37眼进行了平均14 +/- 4个月的随访。平均年龄为54 +/- 26岁。分析了眼压,视力和眼部并发症。结果:共进行了71次治疗。 22眼(59%)进行了1种以上的治疗。预处理的平均眼压为33.1 +/- 3.3毫米汞柱。在最后一次随访中,平均眼压为21 +/- 1.6毫米汞柱。平均总用药量从4.4 +/- 0.5降低至2.4 +/- 0.3。 71种治疗均未发生严重并发症。视力保持稳定的有25眼(67.5%),有6眼(16.2%)有所改善,有6眼(16.2%)有所下降。结论DLPC可有效降低难治性青光眼的眼压。它还可以减少抗青光眼药物的数量。此过程相对安全。但是,可能需要多个DLPC应用程序。版权所有2001 S. Karger AG,巴塞尔

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号